NIH, Panacea Pharmaceuticals, Tandem Labs, PharmaKD, Omicia, BioDiscovery, EBI, Exiqon, Ontario Genomics Institute, Amorfix, Arrayjet, Stratagene, Affymetrix, Strategic Diagnostics, Partners HealthCare, | GenomeWeb
NIH Picks Lung, Ovarian, and Brain Cancers for Cancer Genome Atlas Project
The National Institutes of Health will map lung, brain, and ovarian cancers for its Cancer Genome Atlas project, the agency said this week [see related interview, this issue].
As part of the pilot phase, the NIH plans to map genomic changes in the cancers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.